GLA-AF

BIOLOGICAL4 trials

Sponsors

Rockefeller University, Access to Advanced Health Institute (AAHI), Imperial College London, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIVHealthy VolunteersSchistosomiasis

Phase 1

The Effects of GLA on Human Volunteers

CompletedNCT01397604

Rockefeller UniversityHealthy Volunteers

Start: 2011-07-31End: 2013-03-31Target: 32Updated: 2013-09-23

The Effects of GLA (5 mcg) on Human Volunteers

CompletedNCT01864876

Access to Advanced Health Institute (AAHI)Healthy Volunteers

Start: 2012-09-30End: 2013-12-31Updated: 2014-02-26

Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses

CompletedNCT01922284

Imperial College LondonHIV

Start: 2013-06-30End: 2015-12-31Updated: 2016-09-27

A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults

CompletedNCT03110757

National Institute of Allergy and Infectious Diseases (NIAID)Schistosomiasis

Start: 2018-05-20End: 2019-11-14Updated: 2021-02-02

Related Papers

A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area

PLoS neglected tropical diseases2023-03-3026 citations